Author Manuscript Published OnlineFirst on March 15, 2019; DOI: 10.1158/0008-5472.CAN-18-2376 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Regulation of miRNA biogenesis and histone modification by K63-polyubiquitinated DDX17 controls cancer stem-like features Shih-Han Kao1,2, Wei-Chung Cheng1,2,3, Yi-Ting Wang5, Han-Tsang Wu6, Han-Yu Yeh1, Yu-Ju Chen5, Ming-Hsui Tsai7, Kou-Juey Wu1,2,3,4,8,9,10* 1Research Center for Tumor Medical Science, China Medical University, Taichung 404, Taiwan; 2Drug Development Center, China Medical University, Taichung 404, Taiwan; 3Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan; 4Institute of New Drug Development, China Medical University, Taichung 404, Taiwan; 5Institute of Chemistry, Academia Sinica, Taipei 11529, Taiwan; 6Department of Cell and Tissue Engineering, Changhua Christian Hospital, Changhua City 500, Taiwan; 7Department of Otolaryngology, China Medical University Hospital, Taichung 404, Taiwan; 8Department of Medical Research, China Medical University Hospital, Taichung 404, Taiwan; 9Institute of Cellular and Organismic Biology, Academia Sinica, Taipei 115, Taiwan; 10Cancer Genome Research Center, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan Correspondence should be addressed to: Kou-Juey Wu, Research Center for Tumor Medical Science, Institute of New Drug Development, China Medical University, Taichung 40402, Taiwan; Email:
[email protected] or 1 Downloaded from cancerres.aacrjournals.org on September 30, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on March 15, 2019; DOI: 10.1158/0008-5472.CAN-18-2376 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.